Skip to Main Content

INFORMATION FOR

Select Funding Opportunities

Click here to visit the NCI grant site.

Use your device's search function to find a specific disease or funding source.


Funding

The Vera and Joseph Dresner Foundation MDS Research Fund
The fund will facilitate the advancement of innovative basic science, translational or clinical research to advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders (such as MDS/myeloproliferative neoplasms (MPN) overlap syndromes, secondary acute myeloid leukemia following MDS, idiopathic cytopenia of undetermined significance (ICUS), or clonal hematopoiesis of indeterminate potential (CHIP).

The foundation will consider proposals from individuals at university, college, hospital, or laboratory institutions for support of research in MDS or related disorders in two types:
- Early Career Awards
- Established Investigator Awards

Letter of Intent (LOI) Deadline: LOIs are accepted on a rolling basis.
Learn More>>


Launching soon: ASCI Emerging-Generation Awards

These awards recognize post-MD, pre-career physician-scientists who are meaningfully engaged in immersive research, giving them access to the Joint Meeting and longitudinal programming similar to the YPSA program. Entry into the ASCI network at this stage is intended to provide peer support and inspiration to stay the course into a physician-scientist faculty appointment.

Look for E-Gen Awards nominations to open in late October. Contact programs@the-asci.org for more information.

Conquer Cancer Grants & Awards

These grants and awards support clinical and translational cancer research done by gifted physician-scientists at every stage of their careers, from the best and brightest among young investigators to senior researchers providing mentorship opportunities for the next generation of cancer researchers.

International Innovation Grant (IIG) - Application Deadline: December 2, 2022

Learn more about the Conquer Cancer Grant>>

Time-Sensitive Opportunities for Health Research (R61/R33)

This FOA establishes an accelerated review/award process to support research to understand health outcomes related to an unexpected and/or time-sensitive event (e.g., emergent environmental threat; pandemic; change in local, state, or national policy; natural disaster). Applications in response to this FOA must demonstrate that the research proposed is time-sensitive and must be initiated with minimum delay due to a limited window of opportunity to collect baseline data, answer key research questions, and/or prospectively evaluate a new policy or program.

Application Deadline: November 1, 2023

Michael F. Price Memorial Grant Award for Gastroesophageal Cancer

The DeGregorio Family for Gastric and Esophageal Cancer (Gastroesophageal Cancer) is pleased to announce its 13th annual funding opportunity for gastroesophageal malignancies in honor of Michael F. Price. The Foundation seeks to promote and facilitate collaborative research on the pathogenesis, early diagnosis and treatment of upper gastrointestinal malignancies.

Application Deadline: November 1, 2022

Learn more about the Michael Price Award>>

The Pershing Square Sohn Prize for Young Investigators in Cancer Research

The Pershing Square Sohn Prize for Young Investigators in Cancer Research provides early career, New York area scientists the freedom to take risks and pursue their boldest research at a stage when traditional funding is lacking. Prize winners each receive $200,000 a year for up to three years. At least six grants are awarded annually.

LOI Due: November 7, 2022

Learn more about Pershing Square YI Award>>

Program for the Promotion of Interdisciplinary Team Science (POINTS)

The YSM Office of Team Science will support teams of investigators to address major questions in basic, clinical, and translational science and partner with them on grant submissions to obtain federal funding for sustainable support for these projects. To nucleate new projects, we will provide $50,000 to $200,000 to groups of two to five investigators, led by a YSM faculty member, in support of research projects having the potential to achieve program project or center funding (i.e., U01, U54, P01, P30, P50, comparable large grants from other federal and non-federal agencies).

Application Deadline: November 7, 2022

Learn more about the YSM POINTS>>

Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control, U54)

The purpose of this FOA is to build implementation science centers in low- and middle-income countries (LMICs). This initiative will support implementation science research capacity-building activities, including research projects that identify, develop, and test innovative theory-based strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based cancer control interventions in LMICs.

Application Deadline: November 8, 2022

Learn more about the GlobalISE>>

Lion Heart Fund For Cancer Research

Yale investigators are encouraged to submit proposals of innovative, high-potential projects requiring pilot funding. Projects may be in any area of breast cancer research – basic, translational, clinical, outcomes and population science are all welcomed from any discipline or group of disciplines.

Application Deadline: November 8, 2022

Learn more about the Lion Heart Fund>>

2022 Class of ’61 Cancer Research Award

To recognize significant accomplishment and outstanding promise in cancer research, Yale Cancer Center is pleased to announce the 2022 competition for the Class of ’61 Cancer Research Award. This annual Award recognizes significant accomplishments in cancer research at Yale University by a young member of the faculty, coupled with the expectation for future outstanding contributions to our understanding of the causes of cancer and to the development of novel cancer treatments.

Application Deadline: November 11, 2022


American Cancer Society - Institutional Research Grant Pilot Awards

The purpose of this grant is to provide seed money (up to $40,000 total for one year) for the initiation of promising new projects or novel ideas by Yale Assistant Professors so that they can obtain preliminary results to enable them to compete successfully for national cancer research grants. Investigators who have obtained a competitive national research grant are not eligible for support through this mechanism, unless such a grant is primarily for faculty salary. Recipients of previous ACS-IRG Awards, research grants from National Foundations or the tobacco industry, and established investigators, are also ineligible.

Letters of Intent Due: November 14, 2022

Please email your LOI to CancerFunding@yale.edu by Nov 14, 2022


Technology Impact Award

The Cancer Research Institute Technology Impact Award provides seed funding of up to $200,000 to be used over 12-24 months to address the gap between technology development and clinical application of cancer immunotherapies. These grants aim to encourage collaboration between technology developers and clinical cancer immunologists and to generate the proof-of-principle of a novel platform technology in bioinformatics, ex vivo or in silico modeling systems, immunological or tumor profiling instrumentation, methods, reagents and assays, or other relevant technologies that can enable clinician scientists to generate deeper insights into the mechanisms of action of effective or ineffective cancer immunotherapies.

LOI Due: November 15, 2022


Opn Competition: Environmental influences on Child Health Outcomes (ECHO) Pregnancy Cohort Study Sites (UG3/UH3)

This FOA invites applications for new ECHO Cohort Study Sites to extend and expand the capacity of the ECHO Cohort to further investigate the roles of a broad range of early exposures from society to biology, including the preconception period, on ECHO’s five key child health outcome areas—pre-, peri- and postnatal, upper and lower airways, obesity, neurodevelopment, and positive health—among diverse populations.

Application Deadline: November 21, 2022


Limited Competition: Environmental influences on Child Health Outcomes (ECHO) Pregnancy and Pediatric Cohort Study Sites (UG3/UH3)

This FOA invites applications to renew current ECHO Cohort Study Sites to extend and expand the capacity of the ECHO Cohort to further investigate the roles of a broad range of early exposures from society to biology, including the preconception period, on ECHO’s five key child health outcome areas—pre-, peri- and postnatal, upper and lower airways, obesity, neurodevelopment, and positive health—among diverse populations.

Application Deadline: November 21, 2022


Limited Competition: Environmental influences on Child Health Outcomes (ECHO) Cohort Study Sites for Pediatric Follow Up (UG3/UH3)

This FOA invites applications to renew current ECHO Cohort Study Sites to extend the capacity of the ECHO Cohort to further investigate the roles of a broad range of early exposures from society to biology on ECHO’s five key child health outcome areas—pre-, peri- and postnatal, upper and lower airways, obesity, neurodevelopment, and positive health—among diverse populations.

Application Deadline: November 21, 2022


Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1)
The ‘CASCADE’ Network will conduct pragmatic clinical trials evaluating the effectiveness of clinically proven interventions to overcome barriers and reduce failures in the cervical cancer screening, management, and precancer treatment cascade for women living with HIV.

Letter of Intent Due: November 28, 2022


AACR Clinical Oncology Research (CORE) Training Fellowships
This fellowship is designed for early-career clinical scientists who hold a medical degree (MD, DO, or MD/PhD) and are interested in acquiring the knowledge and skills related to drug development from the perspective of the pharmaceutical industry. The fellow will gain real-world experience in drug development, including clinical research, clinical trial design, and data analysis.

Application Deadline: November 30, 2022


Breast Surgery Fellowships

The term of the Breast Surgical Fellowship is one year with a grant award of $75,000, from August 1 through July 31. Institutions making application for the 2023 award must have an established breast fellowship program, be SSO accredited for a minimum of two years, and be located in New York, New Jersey or Connecticut.

Application Deadline: December 1, 2022


Advanced Training in Artificial Intelligence for Precision Nutrition Science Research (AIPrN) Institutional Research Training Programs (T32)
This FOA invites applications for new institutional training programs (predoctoral, postdoctoral or both) in Artificial Intelligence (AI) for Precision Nutrition (AIPrN) focused on the integration of precision nutrition, AI, machine learning (ML), systems biology, systems science, Big Data, and computational analytics. The goal is to build a future workforce that will be able to use growing data resources to tackle complex biomedical challenges in nutrition science that are beyond human intuition.
Application Deadline: December 8, 2022


BCA Education and Outreach Grants

Breast Cancer Alliance offers grants to support programs directly related to outreach and case managerial breast cancer services, including education, counseling, biopsies and mammograms for the underserved. The programs must be located in Connecticut and/or in Westchester County, New York.

Application Deadline: December 9, 2022


Alex’s Lemonade Stand Foundation 2023 Young Investigator Grant

The Young Investigator grant is a three-year award designed to support early career researchers, such as postdoctoral fellows, clinical fellows or instructors, pursuing promising childhood cancer research ideas. These grants aim to cultivate the best and brightest researchers of the future who demonstrate a commitment to a research career in pediatric cancer. A mentor is required, and a career development plan must be included. The Young Investigator grant offers up to $50,000 in direct costs per year for three years.

Application Deadline: December 12, 2022


AACR Immuno-oncology Research Fellowships

A joint effort to encourage and support postdoctoral or clinical research fellows to conduct immuno-oncology research and to establish a successful career path in this field. The research proposed for funding may be basic, translational, clinical, or epidemiological in nature and must have direct applicability and relevance to immuno-oncology.

Application Deadline: December 14, 2022

Advancing Adolescent Tobacco Cessation Intervention Research (R34/R01)
The purpose of this FOA is to support studies that develop, test, implement, and evaluate behavioral tobacco cessation interventions for adolescents, with a focus on the critical developmental risk period of mid- to late adolescence (approximately 14-20 years old).
Application Opens: December 23, 2022


Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U01)
Through this FOA, the NCI, NIDA, and NCCIH invite applications that propose prospective research studies to assess the benefits and harms of cannabis and cannabinoid use among adult cancer patients during active treatment. NCI, NIDA, and NCCIH are seeking well-designed prospective cohort studies of cancer patients with solid or hematologic tumors currently receiving treatment. Studies are expected to compare cancer patients who use cannabis/cannabinoids with cancer patients that do not use cannabis and/or cannabinoids.

Application Deadline: February 17, 2023


Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01/R21)
Through this FOA, the NCI intends to focus on the biological interactions of cancer health disparities in people living with HIV (PLWH) from underrepresented minority groups through basic mechanistic or translational studies to investigate how HIV interacts with health disparities to promote both non-AIDS and AIDS-defining cancer initiation, progression, and the resulting pathogenic disease sequelae.

Application Deadline: December 15, 2023


NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01)

This Funding Opportunity Announcement (FOA) supports the Cancer Moonshot Scholars Diversity Program (CMSDP) and solicits R01 grant applications that propose independent research projects within the scientific mission of the National Cancer Institute (NCI). The overarching goal of the CMSDP is to increase the number of R01 Early Stage Investigators (ESIs) and enhance the diversity of the cancer research workforce, while promoting scientific advancements in cancer. Investigators from diverse backgrounds, including those from underrepresented groups are encouraged to work with their institutions to apply.

Application Deadline: February 6, 2024